<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=4_Estimates_On_Volasertib_This_Summer</id>
		<title>4 Estimates On Volasertib This Summer - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=4_Estimates_On_Volasertib_This_Summer"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=4_Estimates_On_Volasertib_This_Summer&amp;action=history"/>
		<updated>2026-04-09T09:05:54Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=4_Estimates_On_Volasertib_This_Summer&amp;diff=74040&amp;oldid=prev</id>
		<title>Sextown39 : Page créée avec « LDL-C was directly measured. Lipid and lipoprotein levels were obtained at baseline and at 8 weeks treatment. PON1 activity of the serum samples was measured using full au... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=4_Estimates_On_Volasertib_This_Summer&amp;diff=74040&amp;oldid=prev"/>
				<updated>2017-03-01T19:55:41Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « LDL-C was directly measured. Lipid and lipoprotein levels were obtained at baseline and at 8 weeks treatment. PON1 activity of the serum samples was measured using full au... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;LDL-C was directly measured. Lipid and lipoprotein levels were obtained at baseline and at 8 weeks treatment. PON1 activity of the serum samples was measured using full automated paraoxonase activity measurement kit (Mega Tip, Gaziantep, Turkey) on Hitachi 7600 automatic biochemical analyzer (Hitachi, Tokyo, Japan).11) [https://en.wikipedia.org/wiki/Ritipenem Ritipenem] Statistical analysis All measurements were represented as mean��standard deviation or absolute number (percentage). The patients were divided into two groups according to the changes in HDL-C: increased HDL group [on-treatment HDL-C��baseline HDL-C], and decreased HDL group [on-treatment HDL-C LDL-C levels were 65.5��23.4 mg/dL. Rosuvastatin treatment increased the mean HDL-C concentration by 1.9��9.2 mg/dL (6.4��21.4%). HDL-C levels increased in 138 patients (57.5%), but decreased in 102 patients (42.5%) after statin treatment. The baseline clinical characteristics according to HDL-C response are shown in Table 1. There was no significant difference [http://www.selleckchem.com/products/BI6727-Volasertib.html Volasertib solubility dmso] in the most relevant clinical characteristics between the two groups. Table 1 Baseline clinical characteristics Changes of lipid and lipoprotein Total cholesterol, triglyceride and LDL-C levels decreased after statin treatment [http://www.selleckchem.com/products/cb-839.html selleck chemical] (Table 2). Baseline HDL-C levels were higher in patients with decreased HDL-C at 8 weeks (47.4��10.0 vs. 42.1��9.1 mg/dL, p&lt;/div&gt;</summary>
		<author><name>Sextown39</name></author>	</entry>

	</feed>